Additional file 2: Tables S1a-d. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Munch-Petersen, Helga; Asmar, Fazila; Dimopoulos, Konstantinos; Areškevičiūtė, Aušrinė; Brown, Peter; Girkov, Mia; Pedersen, Anja; Sjö, Lene; Heegaard, Steffen; Broholm, Helle; Kristensen, Lasse; Ralfkiaer, Elisabeth; Grønbæk, Kirsten

Links

[dx.doi.org] | PDF

Tools

Export citation

Search in Google Scholar

Additional file 2: Tables S1a-d. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Published in 2016 by Helga Munch-Petersen, Fazila Asmar, Konstantinos Dimopoulos, Aušrinė Areškevičiūtė, Peter Brown, Mia Girkov, Anja Pedersen, Lene Sjö, Steffen Heegaard, Helle Broholm, Lasse Kristensen, Elisabeth Ralfkiaer, Kirsten Grønbæk

This paper is available in a repository.

Full text: Download

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Abstract

Clinical data in 107 PCNSL patients and TP53, MIR34A, and DAPK subgroups. Tables S2a-b. Disease status (a), and treatment at relapse/progression (b). Tables S3a-d. Immunohistochemical marker expression in 107 PCNSL patients and TP53, MIR34A, and DAPK subgroups. (PDF 534 kb)